S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Intra-Cellular Therapies Announces Topline Safety Results From Phase I/II Clinical Trial for ITI-007 in Healthy Geriatric Subjects and Patients With Dementia|
|Intra-Cellular Therapies Announces Additional Results From Phase I/II Clinical Trial for ITI-007 in Healthy Geriatric Subjects and Patients With Dementia|
|Intra-Cellular Therapies Announces Enrollment of First Patient in Phase 3 Trial of ITI-007 for the Treatment of Schizophrenia|
|Intra-Cellular Therapies to Present Results From Phase I/II Clinical Trial for ITI-007 in Healthy Geriatric Subjects and Patients With Dementia at the American Neurological Association 139th Annual Meeting|
|Intra-Cellular Therapies Reports Third Quarter 2014 Financial Results and Provides Corporate Update|
|Intra-Cellular Therapies and Takeda Announce Mutual Termination of Collaboration to Develop Phosphodiesterase (PDE1) Inhibitors for CNS Disorders|
|Safeguard Scientifics Appoints Mara G. Aspinall to its Board of Directors|
|China train companies have California dreams (2014/10/24)|
|SEC Issued Subpoena to Petrobras to Request Documents (2014/11/24)|
|Lawsuit Alleges Palladium, Platinum Prices Manipulated (2014/11/26)|
Click above to view more mutual fund data and stats for 523610 - ITI Ltd.